Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy

Published:2019-09-03 Issue:1 Volume:17 Page:
ISSN:1477-3155
Container-title:Journal of Nanobiotechnology
language:en
Short-container-title:J Nanobiotechnol

Author:

Gong Chunai,Tian Jing,Wang Zhuo,Gao Yuan,Wu Xin,Ding Xueying,Qiang Lei,Li Guorui,Han Zhimin,Yuan Yongfang,Gao Shen^ORCID

Funder

Clinical Pharmacy Innovation Research Institute of Shanghai Jiao Tong University School of Medicine

National Natural Science Foundation of China

Basic Research Projects of Shanghai Science and Technology Commission

Shanghai Municipal Commission of Health and Family Planning-Construction of clinical pharmacy service system

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Link

http://link.springer.com/content/pdf/10.1186/s12951-019-0526-7.pdf

Reference65 articles.

1. Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363:1938–48.

2. Stevens KN, Vachon CM, Couch FJ. Genetic susceptibility to triple-negative breast cancer. Cancer Res. 2013;73:2025–30.

3. Sparano JA. Defining a role and predicting benefit from platinum-based therapy in breast cancer: an evolving story. J Clin Oncol. 2015;33:1–3.

4. Tung NM, Winer EP. Tumor-infiltrating lymphocytes and response to platinum in triple-negative breast cancer. J Clin Oncol. 2015;33:969–71.

5. Cancello G, Bagnardi V, Sangalli C, Montagna E, Dellapasqua S, Sporchia A, et al. Phase II study with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel with metronomic cyclophosphamide as a preoperative treatment of triple-negative breast cancer. Clin Breast Cancer. 2015;15:259–65.

Cited by 238 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophage metabolic reprogramming-based diabetic infected bone defect/bone reconstruction though multi-function silk hydrogel with exosome release;International Journal of Biological Macromolecules;2024-10

2. Intermittent hypoxic training – derived exosomes in stroke rehabilitation;Frontiers in Integrative Neuroscience;2024-09-11

3. Non-viral gene therapy for neuromuscular diseases including Duchenne muscular dystrophy using nanovesicles derived from human cells;Rare Disease and Orphan Drugs Journal;2024-09-02

4. Hybrid hair follicle stem cell extracellular vesicles co-delivering finasteride and gold nanoparticles for androgenetic alopecia treatment;Journal of Controlled Release;2024-09

5. Correlative expression of exosomal miRNAs in chemotherapy resistance of triple-negative breast cancer: An observational study;Medicine;2024-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3